Bariatric surgery lowers the risk of breast cancer for obese women
Bariatric surgery (reducing the size of the stomach) for severely obese women could lower their breast cancer risk by more than a third, according to a new study.
Axillary node dissection may not be needed for many women with early-stage breast cancer
Ten-year results from a major breast cancer clinical trial suggest that routinely removing the axillary lymph nodes during lumpectomy to remove early-stage breast cancer may not be necessary.
Recommendations for the management of menopausal symptoms in women with breast cancer
Researchers have reviewed the evidence on early menopause in breast cancer patients and have come up with a series of recommendations to safely manage this side-effect.
One year on Herceptin is the gold standard
New research shows that a 12-month treatment programme of Herceptin is still the best option for women with HER2-positive breast cancer, according to the Breast Cancer Aotearoa Coalition (BCAC).
